The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...

New Data Presented at the American Urological Association Annual Meeting Underscores Major Improvement in Quality of Life and Excellent Patient Satisfaction of Innovative Tibial Neuromodulation ...

PARK CITY, Utah--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in implantable Tibial NeuroModulation (iTNM) and the developer of the Revi® System, today announced that new two-year data from its ...

LOS ANGELES, Oct. 15, 2025 /PRNewswire/ -- REVI Credit, a pioneer in compassionate debt recovery and credit rebuilding solutions, today announced the addition of Jason Hansen to its Advisory Board.

BlueWind Medical, Ltd., a leader in implantable Tibial NeuroModulation (iTNM) and developer of the Revi ® System, a patient-centric solution for urgency urinary incontinence (UUI), announced today the ...

"I would run. I would exercise. I would put my hands in warm water. It would cause me to dribble," said Michele Baran about her bladder leakage problem. The 63-year-old already had tried bladder sling ...